Hysteroscopic Evaluation and the Clinical Outcomes of Vaginal Repair of Cesarean Section Scar Defects

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-40
SponsorXinhua Hospital, Shanghai Jiao Tong University School of Medicine

About this trial

Cesarean section scar defects (CSDs) are one of the long-term complications following cesarean section. They can be detected by transvaginal sonography, hysterosalpingography, sonohysterography and magnetic resonance imaging (MRI). Hysteroscopy is frequently used in evaluating endometrial disease. However, the description of CSDs by hysteroscopy is very limited. Only a few papers about hysteroscopy evaluation have been published. This is an exploratory study to compare hysteroscopic findings with the clinical outcomes of vaginal repair of CSDs.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

The inclusion criteria are non-pregnant patients who had one or more cesarean sections, patients who had intermenstrual spotting after the cesarean section or those in which the TRM was less than 3.0 mm at the preoperative stage, and patients who underwent MRI and TVS to evaluate the size of the defect and the TRM before surgery

Disqualifiers

Patients who had a history of chronic diseases (such as cerebro-cardiovascular diseases, malignancies and diabetes mellitus), endocrine disorders, menstrual irregularities before cesarean section, coagulation disorders, use of intrauterine devices, sub-mucous myoma, endometrial diseases, endometrial cysts, uterine fibroids, and adenomyosis after cesarean section

Trial population

Non-pregnant patients who had one or more cesarean sections, patients who had intermenstrual spotting after the cesarean section or those in which the TRM was less than 3.0 mm at the preoperative stage

Trial design

Design model

Ecologic or community

Time perspective

Prospective

Treatments tested in this trial

  • vaginal repair

    Procedure/Surgery

    vaginal repair

Treatment groups

100 Participants
are divided into 1 treatment group
Group A: CSD patients1 intervention

Trial outcomes

Primary outcomes

1

the days of duration of menstruation

duration of menstruation

Time frame
on Days: 1 month
2

the days of duration of menstruation

duration of menstruation

Time frame
on Days: 3 month
3

the days of duration of menstruation

duration of menstruation

Time frame
on Days: 6 month
4

The thickness of the residual myometrium

The thickness of the residual myometrium

Time frame
on Days: 3-6 month

Secondary outcomes

1

number of pregnancy

reproductive information by questionnaire, including abortion, delivery, childbirth, etc.

Time frame
3 years

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: